Torray LLC Incyte Corp Transaction History

Torray LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $8.54 Million - $11.8 Million	-140,377 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $110,802 - $134,707	1,334 Added 0.96%	140,377 $11.7 Million
Q4 2017 Feb 13, 2018	SELL	$93.56 - $116.6 $502,323 - $626,025	-5,369 Reduced 3.72%	139,043 $13.2 Million
Q3 2017 Nov 09, 2017	BUY	$109.15 - $138.27 $15.8 Million - $20 Million	144,412	144,412 $16.9 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Torray LLC, based on Form 13F filings with the SEC.

Stay updated on Torray LLC with notifications on news.